Egbuonu-Davis Lisa 4

What Happened
Lisa Egbuonu-Davis, a director of Phreesia, Inc. (PHR), was granted 19,290 restricted stock units (RSUs) on 2026-06-24 at a grant value of $9.59 per share (total value $184,991). The next day, 2026-06-25, she sold 2,546 shares in an open-market transaction at $9.53 per share for proceeds of $24,263. The RSU grant is an award/acquisition; the sale was a disposition under a pre-established trading plan.

Key Details

• Grant: 19,290 RSUs on 2026-06-24 @ $9.59 — total value $184,991 (reported as an award/acquisition).
• Sale: 2,546 shares on 2026-06-25 @ $9.53 — proceeds $24,263 (reported as an open-market sale).
• Shares owned after transaction: not disclosed in this filing.
• Footnotes: F1 — RSUs represent the contingent right to receive one common share each and vest in full upon the earlier of June 24, 2027 or the next annual meeting. F2 — the sale was executed under a Rule 10b5-1 trading plan adopted Dec 16, 2025.
• Filing timeliness: the report does not indicate a late filing.

Context

• RSU awards are grants that convert to company shares upon vesting; they’re an acquisition-type transaction but do not immediately increase free-floating shares until vested and settled.
• Sales made under a 10b5-1 plan are typically pre-planned and can be routine portfolio-management activity rather than a real-time signal of insider sentiment.
• For retail investors, award grants are information about compensation alignment; purchases are often more directly interpreted as a bullish signal than routine sales.